Tianhui Hu

15PUBLICATIONS
13CO-AUTHORS
BiomaterialsPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 04, 2026
A novel berberine derivative B12 exhibits superior anti-obesity effects via targeting brown and white adipocyte dynamics.

|May 30, 2026
YTHDC1 drives senescence evasion in ovarian cancer through m6A-mediated TERT stabilization.

|Apr 20, 2026
Single-Cell Transcriptomics Reveals the Potential Role of GZMK+ CD8+ T Cells in Cell Senescence of Triple-Negative Breast Cancer.

|Feb 13, 2026
Lentiviral Dendritic Cell Vaccine Targeting Claudin-18.2 Elicits Potent Antitumor Immunity Against Gastric Cancer.

Bowen Zheng, Wenqing Zhang, Dan Zhou

|May 28, 2025
HNF4α-Mediated LINC02560 Promotes Papillary Thyroid Carcinoma Progression by Targeting the miR-505-5p/PDE4C Axis.

Yongcheng Su, Beibei Xu, Chunyi Gao

|May 26, 2025
Developing Dual-State Emission Berberine Derivatives as Theranostic Agents by Reducing Nonradiative Transition Pathways.

Fuquan Xie, Beibei Xu, Peng Chen

Pageof 3

Frequent Collaborators

7 joint publications

Xiaoting Hong

3 joint publications

Li Xiao

2 joint publications

Bowen Zheng

2 joint publications

Liangxi Xie